跳至主要内容
临床试验/NCT05937659
NCT05937659
尚未招募
不适用

Incorporating Biometric Data Evaluation for Patients Receiving Concurrent Chemotherapy and Radiation Therapy

UNC Lineberger Comprehensive Cancer Center2 个研究点 分布在 1 个国家目标入组 20 人2026年5月15日
适应症Cancer

概览

阶段
不适用
干预措施
Biometric Data Collection
疾病 / 适应症
Cancer
发起方
UNC Lineberger Comprehensive Cancer Center
入组人数
20
试验地点
2
主要终点
The rate of technology adoption
状态
尚未招募
最后更新
19天前

概览

简要总结

This study will assess the feasibility of incorporating biometric data via wearable health technology (WHT) into the radiation oncology (RO) clinic workflow for patients receiving concurrent radiation therapy and systemic therapy (CRT) for cancer. The investigators hypothesize that a practical workflow could be created within a busy community RO practice that will allow providers and patients to readily appreciate physiologic declines during concurrent CRT.

Subjects will be asked to wear a device as part of this study that will collect their biometric data (heart rate, number of steps taken per day, etc) called a WHT device throughout their treatment and for 4 weeks afterward. Subjects will be asked to upload the data from their devices onto the computers in the clinic for the assessment.

注册库
clinicaltrials.gov
开始日期
2026年5月15日
结束日期
2027年10月30日
最后更新
19天前
研究类型
Observational
性别
All

研究者

入排标准

入选标准

  • In order to participate in this study a subject must meet all of the eligibility criteria outlined below.
  • All genders aged ≥ 18 years of age.
  • English-speakers
  • Able to understand and cooperate with study procedures.
  • Signed and dated informed consent.
  • Subjects being seen at Novant-New Hanover Regional Medical Center for diagnosis and management of cancer.
  • Subjects prescribed to receive concurrent radiation therapy and systemic therapy either definitively or postoperatively.
  • Signed and dated HIPAA authorization for the release of personal health information.
  • All genders aged ≥ 18 years of age.
  • English speakers.

排除标准

  • Both Subjects and care providers
  • 1\. Has dementia, altered mental status, or any psychiatric or co-morbid condition prohibiting the understanding or rending of informed consent

研究组 & 干预措施

Biometric Data Collection

Adult subjects with cancer and prescribed concurrent systemic therapy and radiation therapy and enrolled in the study.

结局指标

主要结局

The rate of technology adoption

时间窗: Up to 12 weeks

The rate of technology adoption will be quantified as the fraction of subjects who successfully download their WHT data into the research databases in the radiation oncology clinic. Success, on a subject-specific basis, will be defined as their reporting any of their WHT biometric data on \>40% of eligible days.

次要结局

  • Provider perception of the utility(Up to 12 weeks)
  • Subject perception of the utility(Up to 12 weeks)

研究点 (2)

Loading locations...

相似试验